Clinical Trials Directory

Trials / Unknown

UnknownNCT05004506

Intra-articular Analgesia Versus Adductor Canal Block for Arthroscopic Knee Surgery

A Prospective Randomized Controlled Trial of Intra-articular Analgesia Versus Adductor Canal Block for Arthroscopic Knee Surgery

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Loyola University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is a randomized study that compares two commonly used post-operative pain reducing techniques by measuring the level of pain and use of pain medication after knee surgery.

Detailed description

Post-operative pain is a commonly associated with knee surgery. Treatment often includes an oral or intravenous (IV) narcotic regimen which often leads to nausea, vomiting and can cause consti-pation. These issues can contribute to the overall discomfort of the post-operative patient. Intra-operative injections and local nerve blocks have become common adjuncts to narcotics to reduce post-operative pain and the necessity for oral or IV narcotic use. The aim of this study is to com-pare analgesic use and clinical effects on post-operative pain management with intra-articular in-jection of 20ccs of 2% lidocaine with epinephrine at the start of the case plus 20ccs 0.5% mar-caine with epinephrine at the end of the case vs. adductor canal saphenous nerve blockade in pa-tients undergoing knee arthroscopy, as indicated by the need for rescue narcotics and patient pain scores. A randomized, single blinded study will be performed to evaluate post-operative pain control using VAS scores at 1, 2, 4, 8, 12, 24, 36, and 48hrs post-operatively, rescue narcotic use in the PACU, and total narcotic consumption over the same time period.

Conditions

Interventions

TypeNameDescription
DRUGAdductor Canal BlockThe anesthesia provider will identify the adductor canal using ultrasound guidance and inject 15ccs of 0.5% marcaine with epinephrine around the saphenous nerve.
DRUGIntra-articular Injectionreceive 20ccs of 2% lidocaine with epinephrine as an intra-articular injection

Timeline

Start date
2016-04-20
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2021-08-13
Last updated
2022-04-12

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05004506. Inclusion in this directory is not an endorsement.